Infrequent Zoledronate Infusions Reduced Vertebral Fractures Soon After Menopause

by | Jan 16, 2025 | | 0 |

MedPage Today) — Intravenous zoledronate (Reclast) administered once every 5 years reduced the incidence of morphometric vertebral fractures in early postmenopausal women, a randomized trial showed. Over 10 years of follow-up, a new morphometric…

Read More